查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1777372

全球靜脈輸液幫浦市場

Intravenous Infusion Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 307 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球靜脈輸液幫浦市場規模將達 85 億美元

全球靜脈輸液幫浦市場規模預計在2024年為60億美元，預計到2030年將達到85億美元，2024年至2030年的複合年成長率為5.8%。容量輸液幫浦是本報告分析的細分市場之一，預計其複合年成長率為5.1%，到分析期結束時規模將達到25億美元。胰島素輸液幫浦細分市場在分析期間的複合年成長率估計為5.0%。

美國市場預計將達到 16 億美元，中國市場複合年成長率將達到 9.0%

美國靜脈輸液幫浦市場規模預計2024年達到16億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到17億美元，在2024-2030年的分析期間內，複合年成長率為9.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.9%和5.7%。在歐洲，預計德國市場的複合年成長率為3.8%。

全球靜脈輸液幫浦市場－主要趨勢與促進因素摘要

靜脈輸液幫浦如何改變患者照護？

由於精準藥物輸送、醫療自動化以及輸液技術進步的需求不斷成長，靜脈輸液幫浦市場正在經歷顯著成長。靜脈輸液幫浦是關鍵的醫療設備，用於將可控劑量的液體、藥物和營養物質直接輸送到患者血液中。它們在醫院、門診手術中心、居家醫療和加護病房(ICU) 等需要持續輸液、化療、疼痛管理和水合療法的場所中發揮著至關重要的作用。

隨著糖尿病、癌症和心血管疾病等慢性疾病的發生率不斷上升，靜脈輸液幫浦已成為患者長期管理的必需品。此外，智慧輸液幫浦、無線連接和AI輔助劑量調整等技術創新正在徹底改變醫院工作流程、病人安全和用藥準確性。

新冠疫情進一步加速了靜脈輸液幫浦的普及，醫院對自動化、遠端監控輸液系統的需求日益成長，旨在最大限度地減少護理師工作量，加強感染控制，並最佳化重症監護室（ICU）環境下的患者管理。隨著醫療服務提供者持續重視自動化、病患安全以及與數位醫療系統的整合，預計未來幾年輸液幫浦市場將快速成長。

推動輸液幫浦市場發展的主要趨勢是什麼？

輸液幫浦市場最具變革性的趨勢之一是智慧輸液幫浦的興起。這些人工智慧驅動的可程式設計輸液系統配備了給藥錯誤減少系統 (DERS)、即時藥物庫和無線連接，以確保精準用藥，同時減少人為錯誤。智慧型輸液幫浦擴大與電子健康記錄(EHR) 和臨床決策支援系統 (CDSS) 整合，以改善工作流程自動化並最佳化用藥管理。

另一個主要趨勢是門診輸液幫浦在居家照護的應用日益廣泛。隨著居家醫療保健和門診照護的日益普及，輕便便攜的穿戴式式輸液幫浦正被用於慢性病管理、化療、疼痛緩解等。這一趨勢與個人化、以患者為中心的護理模式的轉變相呼應，這種模式在傳統的醫院環境之外提供醫療服務。

無線監控與物聯網輸液幫浦的整合也正在徹底改變整個產業。現代輸液幫浦可將資料即時傳輸到醫院網路或雲端基礎平台，從而實現輸液速率的遠端監控、劑量差異的早期檢測以及預測性維護警報。這項技術提高了病人安全性，減輕了護理人員的工作量，並最大限度地減少了用藥錯誤。

此外，機器人輔助輸液幫浦和人工智慧給藥演算法也已開發出來，以提高藥物輸送的準確性並防止過量用藥。人工智慧輸液系統可以分析患者的生命徵象、藥物交互作用和先前用藥模式，從而動態調整輸液速率，尤其是在重症加護和麻醉管理領域。

另一個新興趨勢是一次性和無針輸液系統的發展。出於對感染控制、交叉污染和針刺傷的擔憂，製造商正在推出一次性和封閉式系統輸液泵，尤其是在腫瘤學、免疫治療和新生兒護理領域。這些創新符合醫院安全通訊協定和感染預防指南。

影響輸液幫浦市場的挑戰有哪些？

儘管靜脈輸液技術發展迅速，但市場仍面臨許多挑戰，包括設備成本高、維護複雜性以及監管障礙。其中最大的擔憂是智慧型輸液幫浦和先進給藥系統的高成本。雖然這些設備能夠提高準確性和安全性，但它們需要在醫院基礎設施、培訓和網路安全方面投入巨額資金，因此中小型醫療機構難以採用。

另一個重大挑戰是輸液幫浦錯誤和設備故障。程式錯誤、機械故障和軟體故障已導致嚴重的用藥錯誤、過量用藥和劑量不足事件，並引發產品召回和監管審查。美國食品藥物管理局 (FDA) 和其他衛生機構已發布有關輸液幫浦故障的安全警告，敦促製造商改善品管、錯誤預防演算法和使用者培訓。

隨著物聯網和無線輸液幫浦的普及，網路安全威脅和資料漏洞構成了另一個挑戰。針對醫院網路的駭客可能會操縱輸液速率或洩露患者數據，導致嚴重的健康風險和責任問題。醫療機構必須實施強大的網路安全通訊協定、加密技術並定期更新軟體，以防止輸液設備遭受潛在的網路攻擊。

複雜的設備互通性以及與醫院IT系統的整合也阻礙了其應用。許多醫院仍在使用過時的電子健康記錄(EHR) 系統，這使得智慧型輸液幫浦難以與現有基礎設施無縫整合。需要進行標準化工作，以確保不同醫療平台之間資料交換的順暢和相容性。

此外，嚴格的監管核准和合規要求也延緩了新型輸液幫浦的上市。輸液幫浦必須符合FDA、CE（歐洲）和ISO（國際標準化組織）關於安全性、劑量準確性和軟體可靠性的嚴格標準。冗長的核准流程增加了創新輸液設備的研發成本和上市時間。

哪些因素推動了靜脈輸液幫浦市場的成長？

輸液幫浦市場的成長受到多種因素的推動，包括慢性病盛行率的上升、醫療技術的進步以及對自動化藥物輸送日益成長的需求。其中最大的促進因素之一是對精準可控的藥物給藥的需求日益成長，尤其是在重症加護、腫瘤科和新生兒護理領域。配備安全機制的智慧輸液幫浦有助於減少用藥錯誤，已成為重症監護室、手術室和兒科病房等高風險環境中的必備設備。

另一個主要促進因素是家庭和門診輸液治療的日益普及。患有糖尿病、癌症和自體免疫疾病等慢性疾病的患者通常需要長期輸液治療，這推動了對攜帶式和穿戴式式輸液泵的需求，這些輸液泵可在院外進行治療。老年人口的成長和遠距遠端醫療服務的興起進一步推動了這一趨勢。

腸外營養和疼痛管理解決方案日益成長的需求也推動了市場的成長。營養不良、胃腸道疾病和術後恢復的患者需要透過輸液幫浦進行靜脈營養，增加了對專用腸內和腸外輸液設備的需求。同樣，患者自控鎮痛 (PCA) 幫浦在術後和安寧療護環境中用於非鴉片類藥物疼痛管理也越來越受歡迎。

新興市場的政府措施和醫療基礎設施現代化計劃也在推動市場擴張。亞太、拉丁美洲和中東地區的國家正在投資先進的醫院設備、數位健康解決方案和智慧輸液系統，以加強患者照護並減少醫院併發症。

此外，個人化醫療和藥物傳遞的興起，也推動了對用於基因治療、免疫治療和標靶癌症治療的專用輸液系統的需求。隨著複雜生物製藥的研發管線不斷擴大，製藥公司正與醫療設備製造商合作，開發用於精準給藥的下一代輸液技術。

結論輸液幫浦技術的未來

隨著醫療機構、居家照護機構和製藥公司採用更智慧、更安全、更有效率的藥物輸送系統，輸液幫浦市場預計將持續成長。隨著人工智慧、機器人技術和數位健康整合技術的進步，輸液幫浦將在個人化醫療、自動化藥物管理和遠端患者監護發揮越來越重要的作用。

在不斷發展的輸液治療領域，重視設備安全、網路安全、法規遵循和無縫醫院整合的製造商將擁有競爭優勢。隨著精準、微創和互聯輸液系統的需求日益成長，輸液治療的未來將由自動化、以患者為中心的解決方案和先進的數位健康生態系統定義。

部分

產品（容積式輸液幫浦、胰島素輸液幫浦、注射輸液幫浦幫浦、腸內輸液幫浦、門診輸液幫浦、病人自控鎮痛、植入式輸液幫浦等）、適應症（化療、糖尿病、胃腸病學、止痛/疼痛管理、小兒科/新生兒科、血液學等）

受訪公司範例

  • Alaris（part of BD）
  • Autoinfu
  • B. Braun Infusomat
  • B. Braun Melsungen AG
  • Baxter International
  • Baxter Sigma Spectrum
  • BD（Becton, Dickinson and Company）
  • Biomedix Medical, Inc.
  • DiaMedical USA
  • Fresenius Kabi
  • ICU Medical
  • IRadimed Corporation
  • Med One Group
  • Medtronic plc
  • Moog Inc.
  • Moog Medical Devices Group
  • Smiths Medical
  • Terumo Corporation
  • Zyno Medical

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地領域專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP31679

Global Intravenous Infusion Pumps Market to Reach US$8.5 Billion by 2030

The global market for Intravenous Infusion Pumps estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Insulin Infusion Pumps segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.0% CAGR

The Intravenous Infusion Pumps market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Intravenous Infusion Pump Market - Key Trends & Drivers Summarized

How Are Intravenous Infusion Pumps Transforming Patient Care?

The intravenous (IV) infusion pump market is experiencing significant growth due to the increasing demand for precision drug delivery, automation in healthcare, and advancements in infusion technology. IV infusion pumps are critical medical devices used to deliver fluids, medications, and nutrients directly into a patient’s bloodstream in controlled amounts. They play a vital role in hospitals, ambulatory surgical centers, home healthcare, and intensive care units (ICUs) for conditions requiring continuous drug infusion, chemotherapy, pain management, and hydration therapy.

With the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, IV infusion pumps have become essential for long-term patient management. Additionally, technological innovations such as smart infusion pumps, wireless connectivity, and AI-driven dosage adjustments are revolutionizing hospital workflows, patient safety, and drug administration accuracy.

The COVID-19 pandemic further accelerated the adoption of IV infusion pumps, as hospitals faced an increased demand for automated and remotely monitored infusion systems to minimize nurse workload, enhance infection control, and optimize patient management in ICU settings. As healthcare providers continue to prioritize automation, patient safety, and integration with digital health systems, the IV infusion pump market is expected to grow rapidly in the coming years.

What Are the Key Trends Driving the IV Infusion Pump Market?

One of the most transformative trends in the IV infusion pump market is the rise of smart infusion pumps. These AI-driven and programmable infusion systems come with dose error reduction systems (DERS), real-time drug libraries, and wireless connectivity, ensuring precise medication administration while reducing human errors. Smart pumps are increasingly being integrated with electronic health records (EHRs) and clinical decision support systems (CDSS) to improve workflow automation and optimize medication dosing.

Another major trend is the increasing adoption of ambulatory infusion pumps for home-based therapy. As home healthcare and outpatient treatment gain popularity, lightweight, portable, and wearable infusion pumps are being used for chronic disease management, chemotherapy, and pain relief treatments. This trend aligns with the shift toward personalized and patient-centric care models, where individuals receive treatment outside of traditional hospital settings.

The integration of wireless monitoring and IoT-enabled infusion pumps is also revolutionizing the industry. Modern IV infusion pumps transmit real-time data to hospital networks and cloud-based platforms, allowing remote monitoring of infusion rates, early detection of dosage discrepancies, and predictive maintenance alerts. This technology enhances patient safety, reduces nurse workload, and minimizes medication errors.

Additionally, robotic-assisted infusion pumps and AI-powered dosing algorithms are being developed to improve drug administration accuracy and prevent overdose risks. AI-driven infusion systems analyze patient vitals, drug interactions, and historical dosage patterns to adjust infusion rates dynamically, particularly in critical care and anesthesia management.

Another emerging trend is the development of disposable and needle-free infusion systems. Concerns over infection control, cross-contamination, and needle-stick injuries have driven manufacturers to introduce single-use and closed-system infusion pumps, particularly for oncology, immunotherapy, and neonatal care applications. These innovations align with hospital safety protocols and infection prevention guidelines.

What Challenges Are Impacting the IV Infusion Pump Market?

Despite the rapid advancements in IV infusion technology, the market faces several challenges, including high device costs, maintenance complexity, and regulatory hurdles. One of the biggest concerns is the high cost of smart infusion pumps and advanced drug delivery systems. While these devices enhance accuracy and safety, they require significant investment in hospital infrastructure, training, and cybersecurity, making adoption difficult for small and mid-sized healthcare facilities.

Another key challenge is infusion pump errors and device malfunctions. Programming errors, mechanical failures, and software glitches have resulted in serious medication errors, overdoses, and under-dosing incidents, leading to product recalls and regulatory scrutiny. The FDA and other health agencies have issued safety alerts regarding infusion pump malfunctions, prompting manufacturers to improve quality control, error prevention algorithms, and user training.

Cybersecurity threats and data vulnerabilities pose another challenge, as IoT-enabled and wireless infusion pumps become more common. Hackers targeting hospital networks could manipulate infusion rates or compromise patient data, leading to serious health risks and liability concerns. Healthcare facilities must implement robust cybersecurity protocols, encryption technologies, and regular software updates to prevent potential cyberattacks on infusion devices.

Complexity in device interoperability and integration with hospital IT systems also hinders adoption. Many hospitals still operate with legacy electronic health record (EHR) systems, making it difficult to seamlessly integrate smart IV pumps with existing infrastructure. Standardization efforts are needed to ensure smooth data exchange and compatibility across different healthcare platforms.

Additionally, stringent regulatory approvals and compliance requirements delay the introduction of new infusion pump models. IV infusion pumps must meet strict FDA, CE (Europe), and ISO (International Organization for Standardization) guidelines regarding safety, dosage accuracy, and software reliability. The lengthy approval process increases R&D costs and time-to-market for innovative infusion devices.

What Factors Are Driving the Growth of the IV Infusion Pump Market?

The growth in the IV infusion pump market is driven by several factors, including the rising prevalence of chronic diseases, advancements in medical technology, and increasing demand for automation in drug delivery. One of the biggest drivers is the growing need for precise and controlled medication administration, particularly in critical care, oncology, and neonatal care. Smart infusion pumps equipped with safety mechanisms help reduce medication errors, making them essential in high-risk environments such as ICUs, operating rooms, and pediatric wards.

Another major driver is the increasing adoption of home-based and ambulatory infusion therapy. Patients with chronic conditions such as diabetes, cancer, and autoimmune disorders often require long-term infusion therapy, leading to the rising demand for portable and wearable IV pumps that enable treatment outside hospital settings. The growing elderly population and the rise of telehealth services further support this trend.

The increasing demand for parenteral nutrition and pain management solutions is also propelling market growth. Patients suffering from malnutrition, gastrointestinal disorders, or post-operative recovery require intravenous feeding via infusion pumps, driving demand for specialized enteral and parenteral infusion devices. Similarly, patient-controlled analgesia (PCA) pumps are gaining popularity for opioid-free pain management in post-surgical and palliative care.

Government initiatives and healthcare infrastructure modernization projects in emerging markets are also fueling market expansion. Countries across Asia-Pacific, Latin America, and the Middle East are investing in advanced hospital equipment, digital health solutions, and smart infusion systems to enhance patient care and reduce hospital-acquired complications.

Furthermore, the rise of personalized medicine and biologic drug delivery is driving demand for specialized infusion systems designed for gene therapy, immunotherapy, and targeted cancer treatments. With the growing pipeline of complex biologic drugs, pharmaceutical companies are partnering with medical device manufacturers to develop next-generation infusion technologies for precision drug administration.

Conclusion: The Future of IV Infusion Pump Technology

The IV infusion pump market is poised for continued growth as healthcare facilities, home-based care providers, and pharmaceutical companies adopt smarter, safer, and more efficient drug delivery systems. With ongoing innovations in AI, robotics, and digital health integration, IV pumps will play an increasingly critical role in personalized medicine, automated drug administration, and remote patient monitoring.

Manufacturers that prioritize device safety, cybersecurity, regulatory compliance, and seamless hospital integration will gain a competitive edge in the evolving infusion therapy landscape. As demand for precision-based, minimally invasive, and connected infusion systems rises, the future of IV therapy will be defined by automation, patient-centric solutions, and advanced digital health ecosystems.

SCOPE OF STUDY:

The report analyzes the Intravenous Infusion Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps, Others); Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Alaris (part of BD)
  • Autoinfu
  • B. Braun Infusomat
  • B. Braun Melsungen AG
  • Baxter International
  • Baxter Sigma Spectrum
  • BD (Becton, Dickinson and Company)
  • Biomedix Medical, Inc.
  • DiaMedical USA
  • Fresenius Kabi
  • ICU Medical
  • IRadimed Corporation
  • Med One Group
  • Medtronic plc
  • Moog Inc.
  • Moog Medical Devices Group
  • Smiths Medical
  • Terumo Corporation
  • Zyno Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravenous Infusion Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Hospitalization Rates and Critical Care Admissions Drive Demand for Intravenous Infusion Pumps
    • Increasing Prevalence of Chronic Diseases and Long-Term Therapies Expands Use of Infusion Pumps in Homecare
    • Growth in Geriatric Population Sustains Demand for Continuous and Controlled Drug Delivery Systems
    • Technological Advancements in Smart Pumps Enhance Safety, Monitoring, and Drug Delivery Precision
    • Integration With EMR and Medication Management Systems Strengthens the Business Case for Smart Infusion Devices
    • Growing Incidence of Medication Errors Spurs Adoption of Dose Error Reduction Systems (DERS) in Infusion Pumps
    • Expansion of Ambulatory and Day-Care Procedures Fuels Demand for Portable and Wearable Infusion Pumps
    • Surge in Chemotherapy, Parenteral Nutrition, and Pain Management Therapies Drives Use in Specialty Care
    • Adoption of Wireless Connectivity and Remote Monitoring Features Creates Differentiation in High-Acuity Settings
    • Increased Investment in Hospital Automation and Digital Infrastructure Propels Infusion System Modernization
    • High Demand for Battery-Powered and Multi-Channel Pumps Enhances Versatility Across Care Settings
    • Growing Focus on Patient-Centric Care Models Drives Development of User-Friendly and Intuitive Pump Interfaces
    • Regulatory Emphasis on Infusion Pump Safety and Post-Market Surveillance Strengthens Product Quality Standards
    • Emergence of Closed-Loop and Autonomous Infusion Technologies Drives R&D Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous Infusion Pumps Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Volumetric Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Insulin Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Syringe Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enteral Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Patient Controlled Analgesia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Implantable Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Analgesia / Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Pediatrics / Neonatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • CHINA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Russia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 137: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Australia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Australia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • INDIA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 140: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 143: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: India Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: India 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: South Korea Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 164: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Argentina Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 176: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Brazil Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Mexico Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 197: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 203: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Iran Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Iran 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 209: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Israel Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Israel 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 215: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 221: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: UAE Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: UAE 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 233: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Africa Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Africa 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030

IV. COMPETITION